Full Text of HR0705 102nd General Assembly
HR0705 102ND GENERAL ASSEMBLY |
| | HR0705 | | LRB102 26364 MST 36527 r |
|
| 1 | | HOUSE RESOLUTION
| 2 | | WHEREAS, Many peoples with serious, chronic mental | 3 | | illness, such as schizophrenia and other schizoaffective | 4 | | disorders, bipolar disorder, or severe depression, require | 5 | | treatment with medications that work as dopamine receptor | 6 | | blocking agents (DRBAs), including antipsychotics; and
| 7 | | WHEREAS, While ongoing treatment with these medications | 8 | | can be very helpful and even lifesaving, for many people, it | 9 | | can also lead to Tardive Dyskinesia (TD); and
| 10 | | WHEREAS, Many people who have gastrointestinal disorders, | 11 | | including gastroparesis, nausea, and vomiting, also require | 12 | | treatment with DRBAs; and | 13 | | WHEREAS, Treatment of gastrointestinal disorders with | 14 | | DRBAs can be very helpful, but for many patients, it can lead | 15 | | to Tardive Dyskinesia; and | 16 | | WHEREAS, Tardive Dyskinesia is a movement disorder that is | 17 | | characterized by random, involuntary, and uncontrolled | 18 | | movements of different muscles in the face, trunk, and | 19 | | extremities; in some cases, people may experience movement of | 20 | | the arms, legs, fingers, and toes; it may affect the tongue, | 21 | | lips, and jaw; symptoms may include swaying movements of the |
| | | HR0705 | - 2 - | LRB102 26364 MST 36527 r |
|
| 1 | | trunk or hips and may impact the muscles associated with | 2 | | walking, speech, eating, and breathing; and | 3 | | WHEREAS, Tardive Dyskinesia can develop months, years, or | 4 | | decades after a person starts taking DRBAs and even after they | 5 | | have discontinued use of those medications; not everyone who | 6 | | takes a DRBA develops TD, but if it develops, it is often | 7 | | permanent; and | 8 | | WHEREAS, Common risk factors for Tardive Dyskinesia | 9 | | include advanced age and alcoholism or other substance abuse | 10 | | disorders; postmenopausal women and people with a mood | 11 | | disorder are also at higher risk of developing Tardive | 12 | | Dyskinesia; and | 13 | | WHEREAS, A person is at higher risk for TD after taking | 14 | | DRBAs for three months or longer, but the longer the person is | 15 | | on these medications then the higher the risk of developing | 16 | | Tardive Dyskinesia; and | 17 | | WHEREAS, Studies suggest that overall risk of developing | 18 | | Tardive Dyskinesia is between 10 and 30 percent; and | 19 | | WHEREAS, It is estimated that over 600,000 Americans | 20 | | suffer from Tardive Dyskinesia; according to the National | 21 | | Alliance for Mental Illness, one in every four patients |
| | | HR0705 | - 3 - | LRB102 26364 MST 36527 r |
|
| 1 | | receiving long-term treatment with an antipsychotic medication | 2 | | will experience Tardive Dyskinesia; and | 3 | | WHEREAS, Years of difficult and challenging research have | 4 | | resulted in recent scientific breakthroughs, with two new | 5 | | treatments for Tardive Dyskinesia approved by the United | 6 | | States Food and Drug Administration; and | 7 | | WHEREAS, Tardive Dyskinesia is often unrecognized, and | 8 | | patients suffering from the illness are commonly misdiagnosed; | 9 | | regular screening for TD in patients taking DRBA medications | 10 | | is recommended by the American Psychiatric Association (APA); | 11 | | and
| 12 | | WHEREAS, Patients suffering from Tardive Dyskinesia often | 13 | | suffer embarrassment due to abnormal and involuntary | 14 | | movements, which leads them to withdraw from society and | 15 | | increasingly isolate themselves as the disease progresses; and
| 16 | | WHEREAS, Caregivers of patients with Tardive Dyskinesia | 17 | | face many challenges and are often responsible for the overall | 18 | | care of the TD patient; and
| 19 | | WHEREAS, The Legislature can raise awareness of Tardive | 20 | | Dyskinesia in the public and in the medical community; | 21 | | therefore, be it
|
| | | HR0705 | - 4 - | LRB102 26364 MST 36527 r |
|
| 1 | | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | 2 | | HUNDRED SECOND GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | 3 | | we declare the week of May 1, 2022 as "Tardive Dyskinesia | 4 | | Awareness Week" in the State of Illinois; and be it further
| 5 | | RESOLVED, That we encourage the citizens of Illinois to | 6 | | become better informed about Tardive Dyskinesia.
|
|